Examkin

Question

Difficulty: MediumImmunologic and Inflammatory Processes

During a follow-up telehealth visit, a rheumatologist is evaluating a patient who was recently started on a chimeric monoclonal antibody for refractory rheumatoid arthritis. The initial infusion was administered 10 days ago without immediate complications. Today, the patient reports a 2-day history of low-grade fever, diffuse joint pain involving the wrists and ankles, and an intensely itchy rash. Photographs uploaded to the patient portal reveal widespread urticarial wheals with scattered areas of purpura. Subsequent laboratory evaluation demonstrates an elevated erythrocyte sedimentation rate and significantly reduced levels of both C3 and C4. Urinalysis shows 1+ proteinuria and 5 to 10 red blood cells per high-power field. Which of the following is the precise immunopathologic mechanism directly responsible for this patient's current clinical presentation?

  1. Consumption of classical pathway complement proteins by circulating antigen-antibody aggregatesAnswer
  2. B
    Massive release of histamine and tryptase following IgE cross-linking on tissue mast cells
  3. C
    Direct binding of therapeutic antibodies to endothelial cell surface antigens leading to cytotoxicity
  4. D
    Sensitization and subsequent activation of tissue macrophages by drug-specific T lymphocytes
  5. E
    Inherited deficiency of early complement factors leading to defective clearance of apoptotic debris

Answer

The clinical presentation is caused by the consumption of classical pathway complement proteins by circulating antigen-antibody aggregates.
The correct answer accurately describes the pathogenesis of serum sickness. Chimeric monoclonal antibodies contain non-human (e.g., murine) protein sequences that the host immune system can recognize as foreign. Approximately 1 to 2 weeks after exposure, the host produces IgG antibodies against the drug. These antibodies bind to the circulating drug to form immune complexes (antigen-antibody aggregates) that deposit in capillary beds of the skin, joints, and kidneys. These deposited complexes activate the classical complement pathway, which heavily consumes C3 and C4 and recruits neutrophils, leading to the clinical triad of rash, polyarthritis, and fever, alongside signs of glomerulonephritis.

Step-by-Step Solution

1
Analyze the timeline and symptoms.
The patient developed fever, polyarthralgia, purpuric urticaria, and glomerulonephritis (proteinuria, hematuria) 10 days after receiving a foreign protein (chimeric antibody).
Establishing the temporal relationship between drug exposure and symptom onset helps categorize the hypersensitivity reaction.
2
Interpret the laboratory findings.
Elevated ESR indicates systemic inflammation, while low C3 and C4 levels indicate classical complement pathway consumption.
Complement levels help differentiate between different inflammatory and immunologic mechanisms.
3
Synthesize findings to identify the precise immunopathology.
The combination of delayed onset, multi-system involvement, and hypocomplementemia is classic for serum sickness, a Type III hypersensitivity reaction mediated by immune complex deposition.
Matching the clinical syndrome with its underlying cellular mechanism confirms the diagnosis and pathophysiology.

Key Concept

Serum sickness is a Type III hypersensitivity reaction characterized by the formation of immune complexes (antigen-antibody aggregates) that deposit in tissues (vessels, joints, glomeruli) and activate the classical complement pathway, leading to hypocomplementemia and systemic inflammation.
Rate this question

Topics

Immunologic and Inflammatory Processes

More questions from this topic